An overview of ALK-positive non-small cell lung cancer
Intended for healthcare professionals
Evidence & Practice Previous     Next

An overview of ALK-positive non-small cell lung cancer

Diana Borthwick Lung cancer nurse specialist, Edinburgh Cancer Centre, Edinburgh
Lavinia Magee Nurse consultant thoracic oncology, Papworth Hospital NHS Foundation Trust, Cambridge
Sarah Smith Lung cancer nurse specialist, North Bristol NHS Trust, Bristol
Rachel Thomas Lung cancer nurse specialist, Guy’s and St Thomas’ NHS Foundation Trust, London

This article provides an overview of ALK-positive non-small cell lung cancer and the types of molecular tests carried out to diagnose the disease. Lung cancer nurse specialists’ role in the treatment pathway is also discussed, as well as the guidance they can provide to help patients understand their diagnosis and its implications.

Cancer Nursing Practice. 15, 10, 26-28. doi: 10.7748/cnp.2016.e1364b

Correspondence

Diana.Borthwick@nhslothian.scot.nhs.uk

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

This supplement has been commissioned and paid for by Novartis. Novartis has funded medical writing support through Nyxeon Healthcare Communications and payment to the journal for advertorial space. All authors contributed equally to the development, design and review of this article; Novartis has reviewed and approved the content

Received: 30 September 2016

Accepted: 07 November 2016

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or